Luca Valenti

Associate Professor @Università Degli Studi Di Milano

Milan, IT
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jan 2016 — Present

Associate Professor @Università Degli Studi Di Milano

View department →

Associate Professor of Internal Medicine at the Fondazione IRCCS Ca\' Granda, Ospedale Maggiore Policlinico

EDUCATION

1994 — 2008

Università degli Studi di Milano

MD

2003 — 2004

Columbia University College of Physicians and Surgeons

Research fellowship

1994 — 2000

Università degli Studi Milano

Degree

SKILLS

Translational ResearchCancer ResearchHospitalsIn VivoOncologyStatisticsMetabolismWestern BlottingMicroscopyTeachingInflammationIron MetabolismClinicalMedical ResearchMetabolic Liver DiseasesEpidemiologyMedicineHepatologyImmunologyAnimal ModelsScienceInternal MedicineBiochemistryImmunofluorescenceMedical EducationInfectious DiseasesHealthcareResearchClinical TrialsElisaLaboratoryCancerClinical ResearchBiotechnologyGeneticsLife SciencesImmunohistochemistryQpcrCell CultureBioinformatics

ABOUT LUCA VALENTI

I am responsible for the Biological Resource Center - Precision Medicine Unit and Omics Lab of Fondazione IRCCS Ca\' Granda Policlinico hospital, University of Milan as an internist and clinical hepatologist, at the Dept of Transfusion Medicine.I design and coordinate clinical translational research and spontaneous clinical trials in the area of steatotic/fatty liver disease (SLD), genetics and iron overload disorders.I coordinate a Research Laboratory of Translational Medicine at Fondazione Ca\' Granda and Università degli Studi di Milano.My main research interest are represent by the genetics of liver diseases and in particular SLD and iron overload, and the relationship between iron metabolism and insulin resistance. We conduct genetic studies in well characterized clinical and population-based cohorts, coupled with translational research with evaluation of biomarkers and biological pathways in clinical samples, and experimental studies in vitro and in vivo.A major focus in the last years has been devoted to the elucidation of the role of genetic variants regulating hepatic lipid metabolism (in particular PNPLA3) and insulin resistance in the progression towards liver fibrosis, hepatocellular carcinoma, and cardiometabolic events, exploring mechanisms and clinical implications for the patients. In parallel, we are contributing to the study of genetic susceptibility to develop COVID-19 and its complications, including long COVID.The major goal is to improve clinical risk stratification and develop innovative treatments for metabolic & ResearcherID: B-36••••09 SCOPUS: 70••••••55

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.